Theron Pharmaceuticals' Unattributed - II Round

Theron Pharmaceuticals raised a round of funding on May 19, 2011.

Theron Pharmaceuticals is a preclinical stage biotechnology company developing an M3 muscarinic antagonist (LAMA) targeting chronic obstructive pulmonary disease (COPD) and asthma markets.…

Articles about Theron Pharmaceuticals' Unattributed - II Round: